Resumen
The hepatic conversion of cholesterol to bile acids is an important mechanism for the elimination of excess dietary cholesterol. Bile acid biosynthesis and transport are regulated by the farnesoid X receptor (FXR), a member of the of nuclear hormone receptor gene superfamily. Thus, therapeutic strategies that target FXR represent a promising new approach for the treatment of hypercholesterolemia. Recent studies have provided new evidence in support of the potential for FXR ligands as antihypercholesterolemic agents.
Idioma original | English |
---|---|
Páginas (desde-hasta) | 275-276 |
Número de páginas | 2 |
Publicación | Trends in Endocrinology and Metabolism |
Volumen | 13 |
N.º | 7 |
DOI | |
Estado | Published - sep. 2002 |
ASJC Scopus Subject Areas
- Endocrinology, Diabetes and Metabolism
- Endocrinology
PubMed: MeSH publication types
- News